We are delighted to announce that 11 of the 14 Contractors who completed Phase 1 have been selected to enter Phase 2 and were awarded contracts on the 15th of November 2022 for development of prototypes based on their Solution Designs.
Further details including the project abstracts can be found under Phase 2 – Prototype Development
The successful Contractors are:
Lot 1: (Consortium Lead)
Integrated DNA Technologies, BV
QIAGEN GmbH
Twist Bioscience Corporation
Lot 3: (Consortium Lead)
BC Platforms AG
Congenica Ltd
FUNDACIO CENTRE DE REGULACIO GENOMICA
Platomics GmbH
Lot 4: (Consortium Lead)
BC Platforms AG
Congenica Ltd
fragmentiX Storage Solutions GmbH
FUNDACIO CENTRE DE REGULACIO GENOMICA